Trial Details
COMPLETEDBasic Information
| Clinical ID | c1318 |
|---|---|
| Identifier | NCT02674308 |
| Trial Title | Entyvio (Vedolizumab) Long Term Safety Study |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis and Crohn's Disease |
| Interventions | DRUG: Vedolizumab|OTHER: Other Biologic Agents |
Participant Information
| Sponsor | Takeda |
|---|---|
| City | Birmingham |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | - |
Time Information
| Start Date | 2015-03-24 |
|---|---|
| Primary Completion Date | 2021-07-30 |
| Completion Date | 2021-07-30 |